0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Contribution |  FREE
Richard P. Gallagher, MA; Jason K. Rivers, MD, FRCPC; Tim K. Lee, MSc; et al.
JAMA. 2000;283(22):2955-2960. doi:10.1001/jama.283.22.2955.

Clinical Crossroads | 
Jennifer Daley, MD; Erin E. Hartman, MS
JAMA. 1998;280(8):736. doi:10.1001/jama.280.8.736.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Dermatology
Case Report/Case Series  | 
BRAFV600E Mutation Status of Involuting and Stable Nevi in Dabrafenib Therapy With or Without Trametinib
Phil McClenahan, BSc; Lynlee L. Lin, BSc; Jean-Marie Tan, MB, BCh, BAO (hons); et al.
JAMA Dermatology
Notable Notes  | 
The Men or Women Behind Nevi: Alfred Guido Miescher
Fabrizio Vaira, MD; Gianluca Nazzaro, MD; Carlo Crosti, MD; et al.
JAMA Dermatology
Notable Notes  | 
The Men or Women Behind Nevi: Richard Sutton
Gianluca Nazzaro, MD; Marco Rovaris, MD
JAMA Dermatology
Original Investigation  | 
Recurrent Melanocytic Nevi and Melanomas in Dermoscopy:  Results of a Multicenter Study of the International Dermoscopy Society
Andreas Blum, MD; Rainer Hofmann-Wellenhof, MD; Ashfaq A. Marghoob, MD; et al.